La Jolla Pharmaceutical (LJPC) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts LJPC Hot Sheet
Price: $6.22 --0%
Financial Fact:
Loss from operations: -15.62M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Loss from operations: -15.62M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
La Jolla Pharmaceutical (NASDAQ: LJPC) reported Q2 EPS of ($2.02), $0.07 worse than the analyst estimate of ($1.95). Revenue for the quarter came in at $1.59 million versus the consensus estimate of $2.4 million.
For earnings history and earnings-related data on La Jolla Pharmaceutical (LJPC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- CalPrivate Bank names Andra Frazier as chief credit officer
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
